Hillsdale Investment Management Inc.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1368465 Toronto, A6

Position in BCRX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$6,084,232

+$1,723,252 QoQ

Shares Held

639,100

+14.3% QoQ

Ownership

0.250%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

Hillsdale Investment Management Inc. holds $42,212,910 across 9 Drug Manufacturers - Specialty & Generic names.

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	649,179	$11,237,288
2	PCRX	Pacira BioSciences, Inc.	362,700	$9,201,699
3	COLL	Collegium Pharmaceutical, Inc	191,600	$6,935,920
4	IRWD	Ironwood Pharmaceuticals Inc	1,250,428	$5,264,301
5	SUPN	Supernus Pharmaceuticals, Inc.	103,680	$4,822,156
6	ANIK	Anika Therapeutics, Inc.	138,821	$2,030,951
7	VTRS	Viatris Inc	117,650	$1,868,282
8	LQDA	Liquidia Corp	6,070	$483,961

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,084,232	639,100	+14.3%	Shares	Sole	2026-05-04
2025-12-31	$4,360,980	559,100	-0.4%	Shares	Sole	2026-02-10
2025-09-30	$4,262,544	561,600	+4.8%	Shares	Sole	2025-11-10
2025-06-30	$4,802,560	536,000	+2.6%	Shares	Sole	2025-08-12
2025-03-31	$3,917,250	522,300	-3.7%	Shares	Sole	2025-05-09
2024-12-31	$4,076,592	542,100	+65213.3%	Shares	Sole	2025-02-11
2024-09-30	$6,308	830	-99.5%	Shares	Sole	2024-11-12
2020-06-30	$818,720	172,000	—	Shares	Sole	2020-08-11
No filing history on record for this holder in this stock.